4
Changes in Ownership
BIO-TECHNE Corp Filed Acc 0000914190-21-000012
Chief Financial Officer sold 10,000 shares at an average $333.63 ($3,336,322)
- Chief Financial Officer acquired 10,000 shares (option exercise)
From the SEC's structured data for this filing
Trades in this filing
Hippel James · Chief Financial Officer
Table I: Non-derivative
7 lines| Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|
| 2021-01-11 | Exercise or conversion : show line 1 in the form | +10,000 | $106.59 | $1,065,900 | 19,137 | D |
| 2021-01-11 | Sale : show line 2 in the form | −400 | $328.68 | $131,472 | 18,737 | D |
| 2021-01-11 | Sale : show line 3 in the form | −400 | $330.27 | $132,106 | 18,337 | D |
| 2021-01-11 | Sale : show line 4 in the form | −700 | $331.61 | $232,127 | 17,637 | D |
| 2021-01-11 | Sale : show line 5 in the form | −2,501 | $333.23 | $833,415 | 15,136 | D |
| 2021-01-11 | Sale : show line 6 in the form | −3,990 | $334.39 | $1,334,219 | 11,146 | D |
| 2021-01-11 | Sale : show line 7 in the form | −2,009 | $334.98 | $672,983 | 9,137 | D |
| Open-market sales · 10,000 sh · avg $333.63 · $3,336,322 | ||||||
Table II: Derivative
1 line| Date | Transaction | Shares | Owned after | D/I |
|---|---|---|---|---|
| 2021-01-11 | Exercise or conversion : show line 8 in the form Stock Options (Right to Buy) | −10,000 | 49,942 | D |
Loading xslF345X03/edgar.xml…